https://staging.xgeneconsulting.com/regulatory-intelligence/ 2026-07-23T01:16:11+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/excelvision-warning-letter-sterility-assurance-failure-and-the-cmc-pattern-every-sterile-products-quality-director-must-recognize/ 2026-07-23T01:16:07+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/wizcure-pharmaa-warning-letter-data-integrity-and-the-cmc-pattern-every-sterile-otc-drug-quality-director-must-recognize/ 2026-07-23T01:16:08+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/babikian-healthcare-products-added-to-import-alert-66-40-the-cgmp-pattern-behind-the-detention-and-what-every-quality-director-managing-dietary-supplement-and-otc-drug-sites-must-know/ 2026-07-23T01:16:09+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/carefusion-213-llc-bd-class-i-recall-chloraprep-sterile-antiseptic-applicators-the-sterile-manufacturing-system-failure-behind-the-recall-and-what-every-aseptic-processing-director-must/ 2026-07-23T01:16:09+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/inside-pharmediums-consent-decree-what-the-terms-reveal-about-fdas-enforcement-standard-and-the-manufacturing-system-it-will-accept/ 2026-07-23T01:16:10+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/zenzi-pharmaceutical-industries-faces-fda-and-ema-simultaneously-what-the-dual-enforcement-action-reveals-about-global-cgmp-standards-and-your-supply-chain-risk/ 2026-07-23T01:16:10+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/catalent-indiana-llc-fda-483-8-observations-at-bloomington-indiana-and-the-aseptic-sterile-manufacturing-pattern-every-sterile-injectable-quality-leader-should-assess/ 2026-07-23T01:16:11+00:00 https://staging.xgeneconsulting.com/regulatory-intelligence/fdas-draft-guidance-on-leveraging-prior-knowledge-for-genome-editing-gene-therapies-the-cmc-precedent-sharing-framework-every-gt-program-should-map-before-september-1/ 2026-07-23T01:16:11+00:00